Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.

OBJECT The spontaneous prognostic factors and optimal therapeutic strategy for WHO Grade II gliomas (GIIGs) have yet to be unanimously defined. Specifically, the role of resection is still debated, most notably because the actual amount of resection has seldom been assessed. METHODS Cases of GIIGs treated before December 2007 were extracted from a multicenter database retrospectively collected since January 1985 and prospectively collected since 1996. Inclusion criteria were a patient age ≥ 18 years at diagnosis, histological diagnosis of WHO GIIG, and MRI evaluation of tumor volume at diagnosis and after initial surgery. One thousand ninety-seven lesions were included in the analysis. The mean follow-up was 7.4 years since radiological diagnosis. Factors significant in a univariate analysis (with a p value ≤ 0.1) were included in the multivariate Cox proportional hazard regression model analysis. RESULTS At the time of radiological diagnosis, independent spontaneous factors of a poor prognosis were an age ≥ 55 years, an impaired functional status, a tumor location in a nonfrontal area, and, most of all, a larger tumor size. When the study starting point was set at the time of first treatment, independent favorable prognostic factors were limited to a smaller tumor size, an epileptic symptomatology, and a greater extent of resection. CONCLUSIONS This large series with its volumetric assessment refines the prognostic value of previously stressed clinical and radiological parameters and highlights the importance of tumor size and location. The results support additional arguments in favor of the predominant role of resection, in accordance with recently reported experiences.

[1]  H. Duffau,et al.  A new tool for grade II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation , 2011, Journal of Neuro-Oncology.

[2]  R. Guillevin,et al.  Natural history of incidental world health organization grade II gliomas , 2010, Annals of neurology.

[3]  R Grant,et al.  Guidelines on management of low‐grade gliomas: report of an EFNS–EANO * Task Force , 2010, European journal of neurology.

[4]  G. Reifenberger,et al.  Molecular diagnostics of gliomas: state of the art , 2010, Acta Neuropathologica.

[5]  F. Ducray,et al.  Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. , 2010, Neuro-oncology.

[6]  Nader Pouratian,et al.  Management of Low-Grade Glioma , 2010, Current neurology and neuroscience reports.

[7]  R. Stupp,et al.  Is there a place for radiotherapy in low-grade gliomas? , 2010, Advances and technical standards in neurosurgery.

[8]  J. Honnorat,et al.  Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas , 2010, Journal of Neuro-Oncology.

[9]  Olga Ciccarelli,et al.  Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. , 2009, Radiology.

[10]  Hugues Duffau,et al.  Surgery of low-grade gliomas: towards a ‘functional neurooncology’ , 2009, Current opinion in oncology.

[11]  Caterina Giannini,et al.  Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. , 2009, Neuro-oncology.

[12]  Luc Taillandier,et al.  Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. , 2009, Neuro-oncology.

[13]  Luc Taillandier,et al.  Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection , 2009, Neurosurgical Review.

[14]  C. Sarkar,et al.  A comparative survival evaluation and assessment of interclassification concordance in adult supratentorial astrocytic tumors , 2009, Pathology Oncology Research.

[15]  Susan M. Chang,et al.  Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. , 2008, Journal of neurosurgery.

[16]  Henry Brem,et al.  EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW‐GRADE GLIOMAS , 2008, Neurosurgery.

[17]  E. Shaw,et al.  Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. , 2008, Journal of neurosurgery.

[18]  M. Berger,et al.  GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME , 2008, Neurosurgery.

[19]  Susan M. Chang,et al.  Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Luc Taillandier,et al.  Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm , 2008, Neurosurgical Review.

[21]  Mitchel S Berger,et al.  Seizure characteristics and control following resection in 332 patients with low-grade gliomas. , 2008, Journal of neurosurgery.

[22]  Caterina Giannini,et al.  Outcome in adult low-grade glioma , 2007, Neurology.

[23]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[24]  Laurent Capelle,et al.  Dynamic history of low‐grade gliomas before and after temozolomide treatment , 2007, Annals of neurology.

[25]  L. Capelle,et al.  French brain tumor data bank: Methodology and first results on 10,000 cases , 2007, Journal of Neuro-Oncology.

[26]  M. Desmurget,et al.  Contrasting acute and slow-growing lesions: a new door to brain plasticity. , 2006, Brain : a journal of neurology.

[27]  Luc Taillandier,et al.  Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas , 2006, Annals of neurology.

[28]  E. Shaw,et al.  Initial report of Radiation Therapy Oncology Group (RTOG) 9802: Prospective studies in adult low-grade glioma (LGG). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  M. Faist,et al.  Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults , 2006, Cancer.

[30]  David Schiff,et al.  Low-grade gliomas: an update on pathology and therapy , 2005, The Lancet Neurology.

[31]  M. Piérart,et al.  Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial , 2005, The Lancet.

[32]  Hugues Duffau,et al.  Intraoperative cortico–subcortical stimulations in surgery of low-grade gliomas , 2005, Expert review of neurotherapeutics.

[33]  D. Áfra,et al.  Supratentorial recurrences of gliomas. Results of reoperations on astrocytomas and oligodendrogliomas , 2005, Acta Neurochirurgica.

[34]  H Duffau,et al.  Correlations between molecular profile and radiologic pattern in oligodendroglial tumors , 2004, Neurology.

[35]  A. Ramaioli,et al.  Long-term outcome of oligodendrogliomas , 2004, Neurology.

[36]  Jacqueline Palace,et al.  The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease , 2004 .

[37]  J. Stevens,et al.  Precise volume measurements of low-grade gliomas. Some surprising findings , 2004 .

[38]  Mitchel S Berger,et al.  Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. , 2004, Journal of neurosurgery.

[39]  D. Spencer,et al.  Low-grade gliomas of chronic epilepsy: A distinct clinical and pathological entity , 1997, Journal of Neuro-Oncology.

[40]  Pascale Varlet,et al.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria , 1997, Journal of Neuro-Oncology.

[41]  W. Powlis,et al.  Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials , 1992, Journal of Neuro-Oncology.

[42]  R. Kortmann Radiotherapy in low-grade gliomas: pros. , 2003, Seminars in oncology.

[43]  F. Langmark,et al.  Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. , 2003, Journal of neurosurgery.

[44]  A. Twijnstra,et al.  Supratentorial grade II astrocytoma: biological features and clinical course , 2003, The Lancet Neurology.

[45]  Laurent Capelle,et al.  Continuous growth of mean tumor diameter in a subset of grade II gliomas , 2003, Annals of neurology.

[46]  J. Rees Low-grade gliomas in adults , 2002, Current opinion in neurology.

[47]  B. Scheithauer,et al.  Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  A. Karim,et al.  Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  E. Laws Resection of low-grade gliomas. , 2001, Journal of neurosurgery.

[50]  M. Berger,et al.  Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. , 2001, Journal of neurosurgery.

[51]  A G Sorensen,et al.  Comparison of diameter and perimeter methods for tumor volume calculation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  L. Deangelis,et al.  Long-term outcome of low-grade oligodendroglioma and mixed glioma , 2000, Neurology.

[53]  B. Fisher,et al.  Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. , 1999, International journal of radiation oncology, biology, physics.

[54]  B. Fisher,et al.  Low Grade Glioma: A Measuring Radiographic Response to Radiotherapy , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[55]  C. Avezaat,et al.  Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery , 1998, Journal of neurology, neurosurgery, and psychiatry.

[56]  P. Black,et al.  Neurosurgical considerations in supratentorial low-grade gliomas: experience with 175 patients. , 1998, Neurosurgical focus.

[57]  K. Skullerud,et al.  Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  B. Fisher,et al.  Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  Patterns of growth of gliomas. , 1995, AJNR. American journal of neuroradiology.

[60]  D. Kondziolka,et al.  Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. , 1995, Journal of neurosurgery.

[61]  P. Kelly Surgical issues in the management of supratentorial low-grade gliomas. , 1995, Clinical neurosurgery.

[62]  I. Fried,et al.  Management of low-grade gliomas: results of resections without electrocorticography. , 1995, Clinical neurosurgery.

[63]  J. Dartigues,et al.  [Supra-tentorial low-grade astrocytomas in adults. Prognostic factors and therapeutic indications. Apropos of a series of 141 patients]. , 1995, Neuro-Chirurgie.

[64]  M. Berger,et al.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas , 1994, Cancer.

[65]  J. Kros,et al.  Oligodendroglioma: the Rotterdam-Dijkzigt experience. , 1994, Neurosurgery.

[66]  A. Fortuna,et al.  Cerebral oligodendroglioma: prognostic factors and life history. , 1994, Neurosurgery.

[67]  B. Scheithauer,et al.  Mixed oligoastrocytomas: a survival and prognostic factor analysis. , 1994, Neurosurgery.

[68]  I. Fried,et al.  Low-grade astrocytomas may arise from different astrocyte lineages. , 1993, Neurosurgery.

[69]  L. Recht,et al.  Suspected low‐grade glioma: Is deferring treatment safe? , 1992, Annals of neurology.

[70]  A. Chiò,et al.  Prognostic factors in well-differentiated cerebral astrocytomas in the adult. , 1989, Neurosurgery.

[71]  W F Taylor,et al.  Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. , 1984, Journal of neurosurgery.